The TARGET BP OFF-MED Trial

Clinical trial NCT03503773 · COMPLETED

Trial details

NCT number: NCT03503773
Sponsor: Ablative Solutions, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension Hypertension,Essential

Start date: 2018-09-24
Primary completion: 2022-01-31
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.